FDA updates labeling for HYDROMORPHONE HYDROCHLORIDE
Labeling changes approved for OSMOTICA PHARM US. Active ingredient: HYDROMORPHONE HYDROCHLORIDE. Decision date: 12/22/2025
Labeling changes approved for OSMOTICA PHARM US. Active ingredient: HYDROMORPHONE HYDROCHLORIDE. Decision date: 12/22/2025
There are no comments here yet...